Annual Report and AGM Notice

RNS Number : 0055R

Alliance Pharma PLC

23 April 2009

 



For Immediate Release

23 April 2009

ALLIANCE PHARMA PLC

('the Company')

Annual Report and AGM Notice

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that its 2008 Annual Report and Notice of the Annual General Meeting, which will be held on 21 May 2009, are now available on the Company's website at www.alliancepharma.co.uk.

Printed copies of both documents have been posted to shareholders today and may also be requested by email at [e-mail].

  For further information: 

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications	+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
Numis Securities	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licenses, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 

END

 

 

MSCGGGZDKZRGLZM